PAI-1 mediates acquired resistance to MET-targeted therapy in non-small cell lung cancer. Thu YM, Suzawa K, Tomida S, Ochi K, et al. PLoS One 2024;19:e0300644.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Thu YM, Suzawa K, Tomida S, Ochi K, et al. PAI-1 mediates acquired resistance to MET-targeted therapy in non-small cell lung cancer. PLoS One 2024;19:e0300644.
PMID: 38758826